Sign in
4

Changes in Ownership

PMV Pharmaceuticals, Inc. Filed Acc 0001209191-22-049692

Chief Medical Officer acquired 52,200 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Alland Leila Chief Medical Officer 2022-09-09 Grant or award +52,200 52,200 D: show line 1 in the form
Loading xslF345X03/doc4.xml…